5Dzy21CO3L | 174402-40-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 5Dzy21CO3L
• 英文别名: 5,21-dihydroxy-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-13-oxa-3,23-diazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4(9),5,7,10,15,17(22),18,20-nonaene-12,14-dione
• CAS: 174402-40-5
• 化学式: C₂₆H₂₀N₂O₁₀
• 分子量: 520.452
• InChiKey: QXKTYTPCXRKYSK-HMEBCMRKSA-N

物化性质

• 沸点：
  932.5±65.0 °C(Predicted)
• 密度：
  2.02±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  38
• 可旋转键数：
  2
• 环数：
  7.0
• sp3杂化的碳原子比例：
  0.23
• 拓扑面积：
  195
• 氢给体数：
  7
• 氢受体数：
  10

反应信息

• 作为反应物：
  描述：

  5Dzy21CO3L 在 肼 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 6-amino-12,13-dihydro-1,11-dihydroxy-13-(β-D-glucopyranosyl)-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione
  参考文献：
  名称：

  Synthesis and biological activities of topoisomerase I inhibitors, 6-N-amino analogues of NB-506

  摘要：

  6-N-Amino analogues of NB-506 [6-N-formylamino-12,13-dihydro-1,11-dihydroxy-13-(beta-D-glucopyranosyl)-5H-indolo [2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione] (3b) were synthesized and tested with respect to topoisomerase inhibition, cytotoxicity and anticancer effects. Among them, a 1,3-dihydroxypropane analogue (J-109,404, St) showed more than ten times more potent anticancer activity in MKN-45 human stomach cancer cells implanted in mice than NB-506. (C) 1999 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(99)00188-2
• 作为产物：
  描述：

  12,13-dihydro-1,11-dihydroxy-13-(β-D-glucopyranosyl)-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione 在 氢氧化钾 作用下， 以 水 为溶剂， 反应 2.0h， 以3.0 g的产率得到5Dzy21CO3L
  参考文献：
  名称：

  Processes for the preparation of indolopyrrolocarbazole derivatives

  摘要：

  公开号：

  EP1264836B1

文献信息

• Synthesis and biological activities of NB-506 analogues: Effects of the positions of two hydroxyl groups at the indole rings
  作者：Mitsuru Ohkubo、Teruyuki Nishimura、Teruki Honma、Ikuko Nishimura、Satoru Ito、Tomoko Yoshinari、Hiroharu Arakawa、Hiroyuki Suda、Hajime Morishima、Susumu Nishimura

  DOI：10.1016/s0960-894x(99)00595-8

  日期：1999.12

  course of a study of 6-N-amino-substituted analogues of NB-506 (1), a more potent anticancer drug, J-109,404 (2), in which the formyl group of NB-506 was replaced with a 1,3-dihydroxypropane group, was reported. A study of further modification in the positions of two hydroxyl groups at the indole rings of 2 resulted in the discovery of a 2,10-dihydroxy analogue, J-107,088 (3), which is a promising anticancer

  在研究NB-506的6-N-氨基取代类似物的过程中，一种更有效的抗癌药物J-109,404（2），其中NB-506的甲酰基被1取代。报道了3-3-二羟基丙烷基团。进一步研究吲哚环2上两个羟基位置的进一步修饰，发现了2,10-二羟基类似物J-107,088（3），这是一种有前途的抗癌药物，其治疗范围比J-109404。
• Indolopyrrolocarbazole derivatives and antitumor agents
  申请人：Banyu Pharmaceutical Co., Ltd.

  公开号：US06703373B1

  公开（公告）日：2004-03-09

  A compound represented by the formula or a pharmaceutically acceptable salt thereof wherein R represents an unsubstituted pyridyl, furyl or thienyl group, or a pyridyl, furyl or thienyl group each of which has one or more substituents selected from the group consisting of a hydroxyl group, a lower alkoxy group, a hydroxy lower alkyl group and a hydroxy lower alkenyl group except that when the pyridyl, furyl or thienyl group has a lower alkoxy group as a substituent, each of which simultaneously has another substituent selected from the group consisting of a hydroxyl group, a lower alkoxy group, a hydroxy lower alkyl group and a hydroxy lower alkenyl group, m represents an integer of 1 to 3, and G represents a &bgr;-D-glucopyranosyl group, and the positions of substitution of the hydroxyl groups on the indolopyrrolocarbazole ring are the 1- and 11-positions, or the 2- and 10-positions, and an antitumore agent containing it as an effective ingredient. The compounds have a better antitumor action than known compounds having a similar structure.

  化合物的化学式为或其药学上可接受的盐，其中R代表未取代的吡啶基，呋喃基或噻吩基，或者是带有一个或多个取代基的吡啶基，呋喃基或噻吩基，所述取代基选自羟基，较低的烷氧基，羟基较低的烷基基团和羟基较低的烯基基团的群，但是当吡啶基，呋喃基或噻吩基带有较低的烷氧基取代基时，每个取代基同时具有羟基，较低的烷氧基，羟基较低的烷基基团和羟基较低的烯基基团中的另一个取代基时，m表示1到3的整数，G表示β-D-葡萄糖吡喃糖基，并且羟基取代在吲哚吡咯喹啉环上的位置为1-和11-位置，或2-和10-位置，以及含有其作为有效成分的抗肿瘤剂。这些化合物比具有类似结构的已知化合物具有更好的抗肿瘤作用。
• Synthesis and biological activities of topoisomerase I inhibitors, 6-N-amino analogues of NB-506
  作者：Mitsuru Ohkubo、Katsuhisa Kojiri、Hisao Kondo、Seiichi Tanaka、Hiroshi Kawamoto、Teruyuki Nishimura、Ikuko Nishimura、Tomoko Yoshinari、Hiroharu Arakawa、Hiroyuki Suda、Hajime Morishima、Susumu Nishimura

  DOI：10.1016/s0960-894x(99)00188-2

  日期：1999.5

  6-N-Amino analogues of NB-506 [6-N-formylamino-12,13-dihydro-1,11-dihydroxy-13-(beta-D-glucopyranosyl)-5H-indolo [2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione] (3b) were synthesized and tested with respect to topoisomerase inhibition, cytotoxicity and anticancer effects. Among them, a 1,3-dihydroxypropane analogue (J-109,404, St) showed more than ten times more potent anticancer activity in MKN-45 human stomach cancer cells implanted in mice than NB-506. (C) 1999 Elsevier Science Ltd. All rights reserved.
• Processes for the preparation of indolopyrrolocarbazole derivatives
  申请人：BANYU PHARMACEUTICAL CO., LTD.

  公开号：EP1264836B1

  公开（公告）日：2004-12-01